StockData
ELVNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Enliven Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$38.70+1.38 (+3.70%)

Close on Oct 19, 2026

Market cap
$2.56B
P/E (TTM)
–
Dividend yield
–

SEC filings

40 of Enliven Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 14, 2026Oct 14, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 5, 2026SEC EDGAR
Current report8-KAug 5, 2026Aug 5, 2026SEC EDGAR
Current report8-KJun 11, 2026Jun 12, 2026SEC EDGAR
Current report8-KJun 11, 2026Jun 11, 2026SEC EDGAR
Current report8-KJun 9, 2026Jun 10, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 7, 2026SEC EDGAR
Current report8-KMay 7, 2026May 7, 2026SEC EDGAR
Proxy statementDEF 14AJun 9, 2026Apr 27, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 3, 2026SEC EDGAR
Current report8-KMar 3, 2026Mar 3, 2026SEC EDGAR
Current report8-KJan 6, 2026Jan 7, 2026SEC EDGAR
Current report8-KDec 9, 2025Dec 11, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 12, 2025SEC EDGAR
Current report8-KNov 12, 2025Nov 12, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 13, 2025SEC EDGAR
Current report8-KAug 13, 2025Aug 13, 2025SEC EDGAR
Current report8-KJun 24, 2025Jun 25, 2025SEC EDGAR
Current report8-KJun 13, 2025Jun 16, 2025SEC EDGAR
Current report8-KJun 13, 2025Jun 13, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 14, 2025SEC EDGAR
Current report8-KMay 14, 2025May 14, 2025SEC EDGAR
Proxy statementDEF 14AJun 24, 2025Apr 28, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 13, 2025SEC EDGAR
Current report8-KMar 13, 2025Mar 13, 2025SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 13, 2024SEC EDGAR
Current report8-KNov 13, 2024Nov 13, 2024SEC EDGAR
Quarterly report10-QJun 30, 2024Aug 13, 2024SEC EDGAR
Current report8-KAug 13, 2024Aug 13, 2024SEC EDGAR
Current report8-KJun 18, 2024Jun 18, 2024SEC EDGAR
Quarterly report10-QMar 31, 2024May 14, 2024SEC EDGAR
Current report8-KMay 14, 2024May 14, 2024SEC EDGAR
Proxy statementDEF 14AJun 18, 2024Apr 26, 2024SEC EDGAR
Current report8-KApr 11, 2024Apr 11, 2024SEC EDGAR
Current report8-KApr 8, 2024Apr 9, 2024SEC EDGAR
Current report8-KMar 19, 2024Mar 19, 2024SEC EDGAR
Annual report10-KDec 31, 2023Mar 14, 2024SEC EDGAR
Current report8-KMar 14, 2024Mar 14, 2024SEC EDGAR
Quarterly report10-QSep 30, 2023Nov 9, 2023SEC EDGAR
Current report8-KNov 9, 2023Nov 9, 2023SEC EDGAR